Literature DB >> 25451370

A survey of Japanese thoracic oncologists' perception of diagnostic and treatment strategies for EGFR mutant or EML4-ALK fusion non-small cell lung cancer.

Katsuyuki Hotta1, Katsuyuki Kiura2, Masahiro Tabata3, Nagio Takigawa4, Mitsune Tanimoto1, Hiroshi Ueoka5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25451370     DOI： 10.1378/chest.14-2055

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  2 in total

Review 1.  Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan.

Authors:  Satoru Senoo; Kiichiro Ninomiya; Katsuyuki Hotta; Katsuyuki Kiura
Journal:  Int J Clin Oncol       Date:  2019-03-07       Impact factor: 3.402

Review 2.  Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets.

Authors:  Mercedes L Dalurzo; Alejandro Avilés-Salas; Fernando Augusto Soares; Yingyong Hou; Yuan Li; Anna Stroganova; Büge Öz; Arif Abdillah; Hui Wan; Yoon-La Choi
Journal:  Onco Targets Ther       Date:  2021-09-01       Impact factor: 4.345
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.